MyFinsight
Home
About
Contact
sabs: the income statement
Download
Download image
Other income
$765,881
(1.49%↑ Y/Y)
Interest income
$655,233
(136.40%↑ Y/Y)
Changes in fair value of
warrant liabilities
-$61,598,908
(-998099.77%↓ Y/Y)
Total other income
$58,124,438
(5954.91%↑ Y/Y)
Warrant issuance cost
$4,852,292
Interest expense
$43,292
(-44.52%↓ Y/Y)
Net income (loss)
$45,445,469
(539.11%↑ Y/Y)
Loss from operations
-$12,678,969
(-12.11%↓ Y/Y)
Total operating
expenses
$12,678,969
(12.11%↑ Y/Y)
General and
administrative
$3,708,959
(6.62%↑ Y/Y)
Research and development
$8,970,010
(14.55%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
SAB Biotherapeutics, Inc. (SABS)
SAB Biotherapeutics, Inc. (SABS)